Jagsonpal Pharmaceuticals informs about disclosure

29 Jul 2021 Evaluate
Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2018, Jagsonpal Pharmaceuticals has informed that it enclosed disclosure of Related Party Transaction, in the format specified in the Accounting Standard for the financial year ended March 31st, 2021.

The above information is a part of company’s filings submitted to BSE.

Jagsonpal Pharma Share Price

334.70 7.65 (2.34%)
07-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1507.00
Dr. Reddys Lab 6037.55
Cipla 1497.30
Zydus Lifesciences 1058.45
Lupin 1630.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.